TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/27/24 16:22 | 9/27/24 | BIOA | Bioage Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Healy James | CA | D | P.d | 12,000 | 18.00 | 0 | 667 | 41 | 2,305 | I | |||||||||||||||
7/3/24 20:04 | 7/1/24 | RAPP | Rapport Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Healy James | CA | D | P | 1,080 | 24.52 | 0 | 44 | 2 | 1,996 | I | |||||||||||||||
6/10/24 19:38 | 6/10/24 | RAPP | Rapport Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Healy James | MA | D | P.d | 9,500 | 17.00 | 0 | 559 | 40 | 1,952 | I | |||||||||||||||
1/31/24 16:10 | 1/30/24 | AVBP | Arrivent Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Healy James | PA | D | P.d | 8,000 | 18.00 | 0 | 444 | 35 | 1,697 | I | |||||||||||||||
8/15/22 15:45 | 8/11/22 | CINC | Cincor Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Healy James | CA | DT | P | 15,180 | 30.00 | 0 | 506 | 9 | 6,109 | I | |||||||||||||||
7/1/22 13:23 | 6/29/22 | KRTX | Karuna Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Healy James | CA | D | P.m | 14,736 | 122.80 | 0 | 120 | 6 | 2,073 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |